Vaxcyte, Inc. PCVX Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s operating lease liabilities (current)?
- Vaxcyte, Inc. (PCVX) reported operating lease liabilities (current) of $6.09M in Q1 2026.
- How has Vaxcyte, Inc.'s operating lease liabilities (current) changed year-over-year?
- Vaxcyte, Inc.'s operating lease liabilities (current) decreased by 0.7% year-over-year, from $6.13M to $6.09M.
- What is the long-term trend for Vaxcyte, Inc.'s operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Vaxcyte, Inc.'s operating lease liabilities (current) has grown at a 46.7% compound annual growth rate (CAGR), from $900K to $6.12M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.